Erythrocyte Sedimentation Rate, an Independent Predictor of Coronary Heart Disease in Men and Women: The Reykjavik Study

American Journal of Epidemiology

Volumn 158, Issue 9, 2003, Pages 844-851

  Andresdottir, Margret B ^a   Sigfusson, Nikulas ^b   Sigvaldason, Helgi ^b   Gudnason, Vilmundur ^b  

^a ICELANDIC HEART ASSOCIATION   (Iceland)

^b NONE

Author keywords

Coronary disease; Inflammation; Risk factors

Indexed keywords

CARDIOVASCULAR DISEASE; GENDER RELATIONS; HEALTH RISK; RISK FACTOR; WOMENS HEALTH;

ADULT; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; RISK ASSESSMENT; SEX DIFFERENCE; STROKE;

AGED; BLOOD SEDIMENTATION; CEREBROVASCULAR ACCIDENT; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; ICELAND; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; RISK FACTORS;

ICELAND;

EID: 0142250426     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwg222     Document Type: Article

References (23)

1. Braunwald E. Shattuck lecture - cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 1997;337:1360-9.
2. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340:115-26.
3. Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-43.
4. Lagrand WK, Visser CA, Hermens WT, et al. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation 1999;100:96-102.
5. Rafnsson V, Bengtsson C. Erythrocyte sedimentation rate and cardiovascular disease. Results from a population study of women in Goteborg, Sweden. Atherosclerosis 1982;42:97-107.
6. Tibblin G, Wilhelmsen L, Werko L. Risk factors for myocardial infarction and death due to ischemic heart disease and other causes. Am J Cardiol 1975;35:514-22.
7. Carlson LA, Böttiger LE, Ahfeldt PE. Risk factors for myocardial infarction in the Stockholm Prospective Study. A 14-year follow-up focussing on the role of plasma triglycerides and cholesterol. Acta Med Scand 1979;206:351-60.
8. Gillum R, Mussolino M, Makuc D. Erythrocyte sedimentation rate and coronary heart disease. The NHANES I Epidemiologic Follow-up Study. J Clin Epidemiol 1995;48:353-61.
9. Tunstall-Pedoe H. Diagnosis, measurement and surveillance of coronary events. Int J Epidemiol 1989;18(suppl):S 169-73.
10. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, et al. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994;90:583-612.
11. Rose GA, Blackburn H. Cardiovascular survey methods. Geneva, Switzerland: World Health Organization, 1968:137-54. (Monograph series no. 56).
12. Davidsson D, Sigfusson N, Björnsson OJ, et al. Erythrocyte sedimentation rate in Icelandic men aged 34-61 years. Iceland Med J 1971;57:79-88.
13. Hardarson T, Gardarsdottir M, Gudmundsson KT, et al. The relationship between educational level and mortality. The Reykjavik Study. J Intern Med 2001;249:495-502.
14. Agnarsson U, Thorgeirsson G, Sigvaldason H, et al. Effects of leisure-time physical activity and ventilatory function on risk for stroke in men. The Reykjavik Study. Ann Intern Med 1999;130:987-90.
15. Rose G, McCartney P, Reid DD. Self-administration of questionnaire on chest pain and intermittent claudication. Br J Soc Med 1977;31:42-8.
16. Gebski V, Leung O, McNeil D, et al. SPIDA user's manual, version 6. New South Wales, Australia: Statistical Computing Laboratory, Macquarie University, 1992.
17. Danesh J, Collins R, Peto R, et al. Haematocrit, viscosity, erythrocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease. Eur Heart J 2000;21:515-20.
18. Jónsdóttir LS, Sigfússon N, Gudnason V, et al. Do lipids, blood pressure, diabetes, and smoking confer equal risk of myocardial infarction in women as in men? The Reykjavik Study. J Cardiovasc Risk 2002;9:67-76.
19. Danesh J, Whincup P, Walker M, et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 2000;321:199-204.
20. Danesh J, Collins R, Appleby P, et al. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 1998;279:1477-82.
21. Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
22. Ridker PM, Rifai N, Clearfield M, et al. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 2001;344:1959-65.
23. Ropes MW, Rossmeisl E, Bauer W. The relationship between ESR and plasma proteins. J Clin Invest 1939;18:791-8.